Baidu
map

Lancet:埃博拉病毒影响了对疟疾病例的管理

2015-07-08 崔倩 译 MedSci原创

正在非洲西部蔓延的埃博拉病毒疫情已经破坏了受影响国家的整个卫生保健系统。由于埃博拉病毒感染与疟疾的症状有一定的重叠性,所以对于疟疾提供的治疗方法对目前埃博拉疾病疫情的间接影响十分敏感。因此研究人员在埃博拉疫情蔓延的背景下以疟疾病例的管理为典型进而据此对埃博拉疾病疫情的影响进行记录。    2014年12月,研究人员对几内亚的公共卫生场所做了一次具有代表性的调查。挑选了

正在非洲西部蔓延的埃博拉病毒疫情已经破坏了受影响国家的整个卫生保健系统。由于埃博拉病毒感染与疟疾的症状有一定的重叠性,所以对于疟疾提供的治疗方法对目前埃博拉疾病疫情的间接影响十分敏感。因此研究人员在埃博拉疫情蔓延的背景下以疟疾病例的管理为典型进而据此对埃博拉疾病疫情的影响进行记录。
    
2014年12月,研究人员对几内亚的公共卫生场所做了一次具有代表性的调查。挑选了四个受到埃博拉病毒影响的地区,同时又随机挑取了未有任何病例报道的地区。分别取60个受埃博拉影响和60个未受埃博拉影响的卫生场所。研究小组从2013年到2014年中的一月至十一月中的疟疾病例管理注册表中抽取若干对象并对卫生保健工作者进行采访。该小组对全国范围内的可疑疟疾病例的周监测数据进行独立性分析。抽取的2014年的疟疾对象数据与之前年份的数据进行对比。
   
研究人员注意到在调查的医疗卫生场所中导致门诊量大幅下降的原因主要包括以下几个方面(214899例中下降了23103例,总比例为11%),发热病例(131330例中下降了20249例,比例为15%),口服(94785例下降了22655,比例为24%)和体外注射(17684例下降了5219例,比例为30%)抗疟疾药物的病例。在埃博拉受灾地区,在98个受访的社区卫生工作者中有73个是具备操作能力的(74%,95% Cl 65-83)并且73个人中有35个人正在积极的应对疟疾病例,相比之下在未感染埃博拉病毒地区,相同方面数据分别为106/112(95%,89-98)和102/106(96%,91-99)。2014年在全国范围的医疗卫生场所中,埃博拉病毒疫情将会导致疟疾病例降低至不到74000例。
    
由于埃博拉疾病疫情的发生而减少了对疟疾疾病的治疗,这种现象威胁到了几内亚疟疾疫情的控制。未处理和处理不当的疟疾病例导致社会上出现过量的疟疾死亡率以及更多的发热病例,这种现象阻碍了对疟疾病毒疾病的确诊。

原始出处:

Dr Mateusz M Plucinski,Timothée Guilavogui, Sidibe Sidikiba,et al.Effect of the Ebola-virus-disease epidemic on malaria case management,Lancet,2015.6.23

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
    2016-04-21 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    期待有更多研究

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
    2015-07-22 1dd90e57m73(暂无匿称)

    本软件里的视频若可下载就好了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
    2015-07-09 huaxipanxing

    看看

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1828170, encodeId=f5b918281e0d1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Apr 21 19:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650339, encodeId=8ac516503396d, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Thu Apr 21 13:52:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35166, encodeId=b38b351660f, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:26:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33310, encodeId=bb6e33310b9, content=本软件里的视频若可下载就好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Wed Jul 22 20:21:00 CST 2015, time=2015-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296446, encodeId=29aa1296446c8, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Fri Jul 10 12:52:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31925, encodeId=abb931925e8, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Thu Jul 09 13:38:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31872, encodeId=1fb1318e270, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhRUzmFEmHvdIaOns4DmF3BicVffXjkOjBTiaMUIA4o7feGvE5IJ0SfSco4ib955Rx7bvWlib7j9V15xp/0, createdBy=814d1631326, createdName=cmn, createdTime=Thu Jul 09 12:03:00 CST 2015, time=2015-07-09, status=1, ipAttribution=)]
    2015-07-09 cmn

    加油

    0

相关资讯

Lancet Infect Dis:埃博拉之下,疟疾防控不容乐观!

 埃博拉病毒在西非地区的持续性传播主要在圭亚那、利比里亚和塞拉利昂三国。埃博拉病毒感染者的高死亡率和高传染性已经使得这些国家的医疗卫生系统处于极其紧张的状态。因此,很少的病人可以使用医疗卫生设施,因为这些设施被关闭了。即使在正常开放的医院、诊所中,因为畏惧埃博拉病毒,门诊病人数也降低至10%。结果是,这些埃博拉疫情地区的疟疾防控近乎停滞,这直接导致了疟疾疫情的爆发和死亡率的上升。疟疾的流

J INFECT DIS: 埃博拉高致病性为哪般?

2014年西非爆发了历史上最严重的一次埃博拉疫情,致死率高达70%。一直以来研究人员认为埃博拉病毒的高毒力与病毒的一种分泌型糖蛋白(sGP)有关。而美国NIH的科学家最新的研究结果表明,sGP并不对埃博拉的高毒力有任何贡献。这篇文章于2015年5月新发表在Journal of infectious disease杂志上。埃博拉病毒的GP基因表达时有可能在RNA水平上7个连续腺嘌呤的位置插入一个腺嘌

mBio:研究发现埃博拉病毒的致命弱点

最近,一个国际研究小组(包括来自美国叶史瓦大学阿尔伯特爱因斯坦医学院和美国陆军传染病医学研究所的科学家),发现了致命埃博拉病毒要进入细胞必须打开的分子“锁”。这项研究是在小鼠中进行的,表明阻断进入这把分子锁的药物,可以防御埃博拉病毒感染。相关研究结果发表在今天出版的在线期刊 mBio 上。研究人员发现,埃博拉病毒不能感染细胞,除非它首先连接到细胞深处膜隔间(称为溶酶体)中的一个宿主蛋白,称为Nie

新病例出现 埃博拉在利比里亚卷土重来?

利比里亚卫生部门官员6月30日证实,一名利比里亚青年感染埃博拉病毒后身亡。这是这一西非国家自5月9日宣布埃博拉疫情结束后出现的首例新病例。利比里亚政府目前已启动应急机制,着手追踪这名死者的密切接触者。【感染跨境?】利比里亚卫生部副部长托尔伯特·涅恩斯瓦说,这名17岁的患者来自马吉比郡,去世前被确诊感染埃博拉病毒。他没有透露这名死者的更多信息,只说医学专家正着手追踪并隔离所有与死者有过密切接触的人。

NEJM:埃博拉病毒可在康复者精液与眼睛中存活长达6个月

一个国际研究小组最新发现,埃博拉病毒不仅可在康复者精液里长时间存活,还能在康复者的眼睛里存活。研究人员说,这一发现凸显了对康复者进行眼部检查的必要性。由美国埃默里大学医院领衔的小组在新一期《新英格兰医学杂志》上报告说,43岁的美国医生伊恩·克罗泽去年9月在塞拉利昂工作期间感染病毒,然后被送到埃默里大学医院治疗了40天,在血液和尿液检测都显示其体内已没有埃博拉病毒后出院。但两个月后,他的左眼出现炎症

Lancet Infect Dis:乌干达埃博拉病毒造成的长期后遗症

背景:长期埃博拉病毒疾病健康结果有限的可用数据表明感染后其后遗症的持续时间超过1年。目前在西非疫情的严重性关于其健康的影响及未来这些患者的医疗需求更需要完整的理解。方法:疫情暴发后的29个月,我们邀请2007年乌干达本迪布焦埃博拉病毒疫情成人幸存者和他们的联系人参加了一项观察性研究。我们收集关于健康状况,功能限制和人口统计数据方面的信息。我们采用ELISA法收集临床化学、血液学和线状病毒抗体的血液

Baidu
map
Baidu
map
Baidu
map